Current Report Filing (8-k)
April 30 2020 - 7:31AM
Edgar (US Regulatory)
0001104506
false
0001104506
2020-04-29
2020-04-30
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
April 30, 2020
INSMED INCORPORATED
(Exact name of registrant as specified
in its charter)
Virginia
|
|
000-30739
|
|
54-1972729
|
(State
or other jurisdiction
|
|
(Commission
|
|
(IRS
Employer
|
of incorporation)
|
|
File Number)
|
|
Identification
No.)
|
700 US Highway 202/206
Bridgewater, New Jersey 08807
(Address of principal executive offices)
(Zip Code)
(908) 977-9900
Registrant's telephone number, including area code:
Not Applicable
(Former name or former address, if changed
since last report.)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of
the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which
registered
|
Common Stock, par value $0.01 per share
|
|
INSM
|
|
Nasdaq Global Select Market
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging
growth company ¨
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
|
Item 2.02.
|
Results of Operations and Financial Condition.
|
On April 30, 2020, Insmed Incorporated issued
a press release regarding its financial results for the three months ended March 31, 2020. A copy of this press release is furnished
herewith as Exhibit 99.1 pursuant to this Item 2.02. The information contained herein, including the exhibit attached hereto, shall
not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except
as shall be expressly set forth by specific reference in such a filing.
|
Item 9.01
|
Financial Statements and Exhibits.
|
(d) Exhibits.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
INSMED INCORPORATED
|
|
|
Dated: April 30, 2020
|
By:
|
/s/ Christine Pellizzari
|
|
Name:
|
Christine Pellizzari
|
|
Title:
|
Chief Legal Officer
|
Insmed (NASDAQ:INSM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Insmed (NASDAQ:INSM)
Historical Stock Chart
From Apr 2023 to Apr 2024